WASHINGTON — Democrats will likely have to axe two provisions from their drug pricing plan to fit in with Senate rules, both of which would have brought down drug prices for people who get health insurance through their jobs.
Democrats had hoped to cap insulin costs for patients with employer-sponsored health insurance in the massive climate, tax, and health bill they’re hoping to advance as soon as this weekend. They also wanted to protect the same pool of people, who get health insurance through their jobs, from bearing the brunt of future drug price hikes.
But the Senate’s rules referee said early Saturday that neither would be allowed under the complicated rules that govern the fast-track process Democrats are using to pass the package without Republican support, according to both public statements and a Senate aide who shared further details.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect